KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Jazz Pharmaceuticals (JAZZ) over the last 15 years, with Q2 2023 value amounting to $63.4 million.

  • Jazz Pharmaceuticals' Shares Outstanding rose 123.76% to $63.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $63.4 million, marking a year-over-year increase of 123.76%. This contributed to the annual value of $63.2 million for FY2022, which is 256.52% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Shares Outstanding of $63.4 million as of Q2 2023, which was up 123.76% from $64.0 million recorded in Q1 2023.
  • In the past 5 years, Jazz Pharmaceuticals' Shares Outstanding ranged from a high of $64.0 million in Q1 2023 and a low of $55.4 million during Q1 2020
  • Its 5-year average for Shares Outstanding is $59.3 million, with a median of $59.0 million in 2019.
  • Its Shares Outstanding has fluctuated over the past 5 years, first plummeted by 629.25% in 2019, then soared by 1041.16% in 2021.
  • Jazz Pharmaceuticals' Shares Outstanding (Quarter) stood at $56.1 million in 2019, then grew by 0.06% to $56.2 million in 2020, then grew by 9.72% to $61.6 million in 2021, then grew by 2.57% to $63.2 million in 2022, then rose by 0.29% to $63.4 million in 2023.
  • Its Shares Outstanding stands at $63.4 million for Q2 2023, versus $64.0 million for Q1 2023 and $63.2 million for Q4 2022.